Literature DB >> 22354225

Pulmonary venous obstruction in the atrial switch operation: a forgotten complication.

Robert W Elder1, William E Hellenbrand.   

Abstract

The reported case involved a 7-year-old girl with congenitally corrected transposition of the great arteries (ccTGA) and situs inversus who after surgical management experienced symptoms of dyspnea and left-sided obstructive heart disease. Her symptoms, chest X-ray, and cardiac catheterization demonstrated pulmonary venous obstruction, a known but rare complication associated with intra-atrial baffle obstruction. The incidence of the reported disorder, the follow-up assessment, and the current literature regarding complications of Senning/Mustard surgery are discussed in the context of patients with ccTGA.

Entities:  

Mesh:

Year:  2012        PMID: 22354225     DOI: 10.1007/s00246-012-0241-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  Midterm results after restoration of the morphologically left ventricle to the systemic circulation in patients with congenitally corrected transposition of the great arteries.

Authors:  Stephen M Langley; David S Winlaw; Oliver Stumper; Rami Dhillon; Joseph V De Giovanni; John G Wright; Paul Miller; Babulal Sethia; David J Barron; William J Brawn
Journal:  J Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 5.209

2.  Proceedings: Congenitally corrected transposition of the great arteries: a clinical study of 101 cases.

Authors:  B B Bjarke; B S Kidd
Journal:  Br Heart J       Date:  1976-05

3.  Late development of pulmonary venous obstruction following Mustard's operation using a dacron baffle.

Authors:  D J Driscoll; M R Nihill; T A Vargo; C E Mullins; D G McNamara
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

Review 4.  The double switch operation with accent on the Senning component.

Authors:  Roger B B Mee
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2005

5.  Late postoperative hemodynamic results and cineangiocardiographic findings after Mustard atrial baffle repair for transposition of the great arteries.

Authors:  P M Clarkson; J M Neutze; B G Barratt-Boyles; P W Brandt
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

6.  Long-term outcome of surgically treated patients with corrected transposition of the great arteries.

Authors:  Viktor Hraska; Brian W Duncan; John E Mayer; Michael Freed; Pedro J del Nido; Richard A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2005-01       Impact factor: 5.209

7.  Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience.

Authors:  M Gelatt; R M Hamilton; B W McCrindle; M Connelly; A Davis; L Harris; R M Gow; W G Williams; G A Trusler; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1997-01       Impact factor: 24.094

Review 8.  Transposition of the great arteries.

Authors:  Carole A Warnes
Journal:  Circulation       Date:  2006-12-12       Impact factor: 29.690

9.  Late development of severe pulmonary venous obstruction following the Mustard operation.

Authors:  M A Berman; P S Barash; W E Hellenbrand; H C Stansel; N S Talner
Journal:  Circulation       Date:  1977-09       Impact factor: 29.690

10.  Results of the double switch operation for congenitally corrected transposition of the great arteries.

Authors:  Mohamedou Ly; Emre Belli; Bertrand Leobon; Chokri Kortas; Oswin E Grollmüss; Dominique Piot; Claude Planché; Alain Serraf
Journal:  Eur J Cardiothorac Surg       Date:  2009-04-05       Impact factor: 4.191

  10 in total
  1 in total

1.  Comparison of systemic right ventricular function in transposition of the great arteries after atrial switch and congenitally corrected transposition of the great arteries.

Authors:  Michael Morcos; Philip J Kilner; David J Sahn; Harold I Litt; Emanuela R Valsangiacomo-Buechel; Florence H Sheehan
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-01       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.